Katelyn JetelinaMPH, PhD · epidemiologist and public-health science communicator
Treat the dose as a current, risk-stratified option and make the decision using age, health, pregnancy, prior infection and current guidance.
What it rests onHer seasonal guide separates population recommendations instead of issuing one universal instruction.
Source: yourlocalepidemiologist.substack.com ↗
Vinay PrasadMD, MPH · hematologist-oncologist and professor of epidemiology and biostatistics
Do not routinely recommend updated doses to healthy young people without randomized evidence of meaningful net benefit.
What it rests onHis published position emphasizes low absolute risk, uncertain incremental benefit and myocarditis.
Source: sensible-med.com ↗
Older adults, pregnancy, immunocompromise, prior infection and a healthy young adult are different populations. Product and season also matter.
Absolute benefit and risk vary by person, and recommendations should be transparent about uncertainty.
Large randomized trials or strong current comparative evidence on severe outcomes and important adverse events by age, sex, prior infection and product.
You do, and your call is dated, kept, and yours to change. Follow the people you already trust and what they publish turns into a short daily practice.
Free to sign up and use. We do not ask for a card.